Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX(®) Vaccine-Induced IgG Antibodies in Zambian Children

Developing a broadly protective vaccine covering most ETEC variants has been elusive. The most clinically advanced candidate yet is an oral inactivated ETEC vaccine (ETVAX(®)). We report on the use of a proteome microarray for the assessment of cross-reactivity of anti-ETVAX(®) IgG antibodies agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Mubanga, Cynthia, Simuyandi, Michelo, Mwape, Kapambwe, Chibesa, Kennedy, Chisenga, Caroline, Chilyabanyama, Obvious Nchimunya, Randall, Arlo, Liang, Xiaowu, Glashoff, Richard H., Chilengi, Roma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224314/
https://www.ncbi.nlm.nih.gov/pubmed/37243042
http://dx.doi.org/10.3390/vaccines11050939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224314/
https://www.ncbi.nlm.nih.gov/pubmed/37243042
http://dx.doi.org/10.3390/vaccines11050939

Ejemplares similares